MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ADCT made $81,357K in revenue. -$142,623K in net income. Net profit margin of -175.31%.

Income Overview

Revenue
$81,357K
Net Income
-$142,623K
Net Profit Margin
-175.31%
EPS
-$1.12
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License And Royalty Revenue
Revenue Breakdown
    • Product
    • License Revenues
    • Royalty Revenue

Income Statement
2025-12-31
2024-12-31
Total revenue, net
81,357 70,837
Cost of product sales
5,798 5,949
Research and development
104,005 109,633
Selling and marketing
43,374 44,015
General and administrative
36,559 41,894
Restructuring, impairment and other related costs
13,120 -
Total operating expense
202,856 201,491
Loss from operations
-121,499 -130,654
Interest income
8,810 12,272
Deferred royalty obligation interest expense
35,346 -
Effective interest expense on senior secured term loan facility
16,275 -
Other interest expense
12 -
Interest expense
51,633 50,211
Other, net
22,714 12,457
Total other expense, net
-20,109 -25,482
Loss before income taxes
-141,608 -156,136
Income tax expense
1,015 166
Loss before equity in net losses of joint venture
-142,623 -156,302
Equity in net losses of joint venture
0 -1,544
Net loss
-142,623 -157,846
Basic EPS
-1.12 -1.62
Diluted EPS
-1.12 -1.62
Basic Average Shares
127,067,540 97,159,966
Diluted Average Shares
127,067,540 97,159,966
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$142,623K (9.64%↑ Y/Y)Loss before equity innet losses of joint...-$142,623K (8.75%↑ Y/Y)Loss before incometaxes-$141,608K (9.30%↑ Y/Y)Income tax expense$1,015K (511.45%↑ Y/Y)Product$73,551K (6.16%↑ Y/Y)License And RoyaltyRevenue$7,806K Loss from operations-$121,499K (7.01%↑ Y/Y)Total other expense,net-$20,109K (21.09%↑ Y/Y)Total revenue, net$81,357K (14.85%↑ Y/Y)Other, net$22,714K (82.34%↑ Y/Y)Interest income$8,810K (-28.21%↓ Y/Y)Total operatingexpense$202,856K (0.68%↑ Y/Y)Interest expense$51,633K (2.83%↑ Y/Y)Research and development$104,005K (-5.13%↓ Y/Y)Selling and marketing$43,374K (-1.46%↓ Y/Y)General andadministrative$36,559K (-12.73%↓ Y/Y)Restructuring, impairment andother related costs$13,120K Cost of product sales$5,798K (-2.54%↓ Y/Y)Deferred royaltyobligation interest...$35,346K (5.17%↑ Y/Y)Effective interestexpense on senior...$16,275K (-1.97%↓ Y/Y)Other interestexpense$12K (1100.00%↑ Y/Y)

ADC Therapeutics SA (ADCT)

ADC Therapeutics SA (ADCT)